131 related articles for article (PubMed ID: 8748457)
1. Specific selection of deoxycytidine kinase mutants with tritiated deoxyadenosine.
Chan TS; Nelson JA
Biochem Genet; 1995 Oct; 33(9-10):327-40. PubMed ID: 8748457
[TBL] [Abstract][Full Text] [Related]
2. Adenosine kinase deficiency in tritiated deoxyadenosine-resistant mouse S49 lymphoma cell lines.
Sastry KJ; Huang C; Chan TS
Biochem Genet; 1987 Dec; 25(11-12):765-77. PubMed ID: 2835956
[TBL] [Abstract][Full Text] [Related]
3. Isolation and characterization of S49 mouse lymphoma cell mutants deficient in adenosine deaminase.
Chan TS; Huang C; Sato T
Somat Cell Mol Genet; 1989 Sep; 15(5):411-20. PubMed ID: 2789437
[TBL] [Abstract][Full Text] [Related]
4. Deoxyadenosine toxicity and cell cycle arrest in hydroxyurea-resistant S49 T-lymphoma cells.
Albert DA; Nodzenski E
Exp Cell Res; 1988 Dec; 179(2):417-28. PubMed ID: 3056732
[TBL] [Abstract][Full Text] [Related]
5. Identification of the mechanism of activation of 9-beta-D-arabinofuranosyladenine in human lymphoid cells using mutants deficient in nucleoside kinases.
Verhoef V; Sarup J; Fridland A
Cancer Res; 1981 Nov; 41(11 Pt 1):4478-83. PubMed ID: 6272978
[TBL] [Abstract][Full Text] [Related]
6. Deoxynucleoside overproduction in deoxyadenosine-resistant, adenosine deaminase-deficient human histiocytic lymphoma cells.
Kubota M; Carrera CJ; Wasson DB; Carson DA
Biochim Biophys Acta; 1984 May; 804(1):37-43. PubMed ID: 6372866
[TBL] [Abstract][Full Text] [Related]
7. Effects of mutational loss of nucleoside kinases on deoxyadenosine 5'-phosphate/deoxyadenosine substrate cycle in cultured CEM and V79 cells.
Bianchi V; Ferraro P; Borella S; Bonvini P; Reichard P
J Biol Chem; 1994 Jun; 269(24):16677-83. PubMed ID: 8206987
[TBL] [Abstract][Full Text] [Related]
8. Activation of deoxycytidine kinase by deoxyadenosine: implications in deoxyadenosine-mediated cytotoxicity.
Keszler G; Virga S; Spasokoukotskaja T; Bauer PI; Sasvari-Szekely M; Staub M
Arch Biochem Biophys; 2005 Apr; 436(1):69-77. PubMed ID: 15752710
[TBL] [Abstract][Full Text] [Related]
9. S-adenosylhomocysteine hydrolase inactivation and purine toxicity in cultured human T- and B-lymphoblasts.
Young GJ; Hallam LJ; Jack I; Van Der Weyden MB
J Lab Clin Med; 1984 Jul; 104(1):86-95. PubMed ID: 6330251
[TBL] [Abstract][Full Text] [Related]
10. Deoxyadenosine/deoxycytidine kinase from Bacillus subtilis. Purification, characterization, and physiological function.
Møllgaard H
J Biol Chem; 1980 Sep; 255(17):8216-20. PubMed ID: 6251049
[TBL] [Abstract][Full Text] [Related]
11. Human placental deoxyadenosine and deoxyguanosine phosphorylating activity.
Hurley MC; Palella TD; Fox IH
J Biol Chem; 1983 Dec; 258(24):15021-7. PubMed ID: 6317685
[TBL] [Abstract][Full Text] [Related]
12. Characterization of an adenosine deaminase-deficient human histiocytic lymphoma cell line (DHL-9) and selection of mutants deficient in adenosir kinase and deoxycytidine kinase.
Kubota M; Kamatani N; Daddona PE; Carson DA
Cancer Res; 1983 Jun; 43(6):2606-10. PubMed ID: 6303563
[TBL] [Abstract][Full Text] [Related]
13. Deoxycytidine kinase-mediated toxicity of deoxyadenosine analogs toward malignant human lymphoblasts in vitro and toward murine L1210 leukemia in vivo.
Carson DA; Wasson DB; Kaye J; Ullman B; Martin DW; Robins RK; Montgomery JA
Proc Natl Acad Sci U S A; 1980 Nov; 77(11):6865-9. PubMed ID: 6256765
[TBL] [Abstract][Full Text] [Related]
14. Genetic analysis of deoxyadenosine toxicity in dividing human lymphoblasts.
Carson DA; Carrera CJ; Kubota M; Wasson DB; Iizasa T
Adv Exp Med Biol; 1986; 195 Pt B():207-11. PubMed ID: 3020905
[No Abstract] [Full Text] [Related]
15. Study of the efficacy of a pronucleotide of 2-chloro-2'-deoxyadenosine in deoxycytidine kinase-deficient lymphoma cells.
Bontemps F; Meier C; Delacauw A; Balzarini J; Galmarini C; van den Neste E
Nucleosides Nucleotides Nucleic Acids; 2006; 25(9-11):997-1000. PubMed ID: 17065053
[TBL] [Abstract][Full Text] [Related]
16. 2'-Deoxyadenosine selectively kills nonneuronal cells without affecting survival and growth of chick dorsal root ganglion neurons.
Wakade AR; Kulkarni JS; Fujii JT
Brain Res; 1998 Mar; 788(1-2):69-79. PubMed ID: 9554958
[TBL] [Abstract][Full Text] [Related]
17. Selection and characterization of mutant S49 T-lymphoma cell lines resistant to phosphonoformic acid: evidence for inhibition of ribonucleotide reductase.
Albert DA; Gudas LJ
J Cell Physiol; 1986 May; 127(2):281-7. PubMed ID: 2939095
[TBL] [Abstract][Full Text] [Related]
18. Substrate specificity of human deoxycytidine kinase toward antiviral 2',3'-dideoxynucleoside analogs.
Kierdaszuk B; Bohman C; Ullman B; Eriksson S
Biochem Pharmacol; 1992 Jan; 43(2):197-206. PubMed ID: 1739408
[TBL] [Abstract][Full Text] [Related]
19. Purine nucleoside kinases in human T- and B-lymphoblasts.
Yamada Y; Goto H; Ogasawara N
Biochim Biophys Acta; 1983 Nov; 761(1):34-40. PubMed ID: 6315069
[TBL] [Abstract][Full Text] [Related]
20. Genetic analysis of 2',3'-dideoxycytidine incorporation into cultured human T lymphoblasts.
Ullman B; Coons T; Rockwell S; McCartan K
J Biol Chem; 1988 Sep; 263(25):12391-6. PubMed ID: 2842332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
